Skip to content
Uplink Ventures Blog

The Zimbabwean Government Declines ‘Unbalanced’ American Health Aid Deal Due to Data Concerns

Health aid image
The offered US financial assistance was aimed at programmes for treating and preventing HIV/Aids, TB, and malaria.

Zimbabwe has rejected a significant US healthcare agreement worth $367m (272 million pounds) spanning five years due to Washington's demand for confidential data.

This move was revealed following a government memo from December was leaked, revealing that President Emmerson Mnangagwa felt the agreement was "lopsided".

A government representative later explained that the US was seeking biological samples for research and commercial gain while refused to share the benefits from any future medical innovations.

"We will now turn to the challenging and unfortunate task of winding down our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.

The US Embassy noted the US had provided more than $1.9bn for health programmes to Zimbabwe over the last twenty years.

A physicians' group in Zimbabwe has called for continued dialogue to reach a deal agreeable to both sides so the nation's critical HIV treatment initiative can proceed.

Wider Background

This development comes after a similar situation in Kenya, where a court blocked a similar health funding agreement after legal challenges were raised about the safety of citizens' medical information.

Since returning to office recently, US President Donald Trump has reduced foreign aid and closed the key foreign aid agency.

The agency had administered aid for the American government, but Trump argued its spending was "inefficient" and his government was pursuing direct bilateral agreements to boost transparency and responsibility.

Based on reports, 16 African countries have to date agreed to similar health pacts, representing more than $18.3bn in committed funds.

Specifics of the Rejected Agreement

This assistance for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and preparing for epidemics".

"It is our view this collaboration might have yielded extraordinary advantages for the people of Zimbabwe, especially the 1.2 million currently receiving antiretroviral therapy through US-supported programmes," Tremont said.

However, official spokesman Nick Mangwana argued the arrangement was "unequal".

"Our nation was requested to surrender its genetic material and health information over an extended period, without any equivalent assurance of access to any medical innovations – such as new medicines or tests – that might be developed from that shared data," he stated.

"In essence, our nation would provide the raw materials for scientific discovery with no certainty that the end products would be available to our people should a future health crisis emerge."

National Interest and Global Health

He also noted that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral health agreements were undermining structures previously set up through the international health agency.

Mangwana gave as an example its Pathogen Access and Benefit Sharing system designed to deal with future global health emergencies.

"This framework is designed to ensure that when a country contributes its data, the benefits – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the resources to create them."

These objections over the US deal "are not meant as hostility towards the US," he added.

"We welcome continued dialogue with our US partners on how future co-operation could be arranged in a manner that respects the sovereignty and dignity of each country."

Health Experts Response

Medical experts expressed it recognised the official position, but suggested that negotiations must proceed given that a large portion of the country's Aids initiatives were funded by foreign aid.

"Where technical issues exist, including those relating to information security or implementation frameworks, these can often be resolved via technical clarification and negotiated safeguards," the group added.

The situation emphasises the continuing challenges between receiving much-needed foreign assistance and safeguarding national sovereignty in an ever more interconnected world.

About the author

James Vasquez

Maya Chen is a venture capital analyst with over a decade of experience in tech startups and investment strategy, specializing in emerging markets.

Uplink Ventures Blog

Type to search articles.